Caring for the world, one person at a time, inspires and unites the people of Johnson & Johnson. We embrace innovation bringing ideas, products, and services to life to advance the health and well-being of people around the world. We believe in collaboration which has led to breakthrough after breakthrough, from medical miracles that have cha ...
nged lives, to consumer products that make every day a little better.
Our over 125000 employees in 60 countries are united in a common mission: To help people everywhere live longer, healthier, happier lives. DPDS (Discovery, Pharmaceutical Development & Supply) is the molecular invention engine for
Johnson & Johnson, focused on where people are passionate about being the fastest at translating the best ideas into unique outstanding therapies for patients. Comprised of ~4,200 employees around the world, DPDS partners with other global functions to deliver sustained product innovation from target identification through end-of-product life across all therapeutic modalities, including Small Molecules, Proteins, RNA Therapy, Gene Therapy & Cell Therapy.
The Johnson & Johnson campus in Beerse, Antwerp (Belgium) has a unique ecosystem covering the complete drug development life cycle, with all capabilities from basic science to market access on one campus. The integrated environment of our campus gives our people the chance to experience many different aspects of drug development throughout their careers. It has a successful track record of over sixty years of drug discovery and development and is one of the most important innovation engines of the Johnson & Johnson group worldwide.
Within DPDS, our Global Medicinal Chemistry (GDC) team is focused on progressing small molecule projects from a hit to clinical candidate.
For this internship within GDC, the candidate will participate in a Hit-to-Lead or Lead Optimization project for one of our therapeutic areas. While a main activity will be the synthesis of novel molecules, the candidate will also be involved in the design of new molecules and will be exposed to the multi-parameter optimization in the project. There may also be a possibility to get involved in Targeted Protein Degradation (TPD) or peptide projects.
During the internship, the student will be trained to independently synthesize and characterize target molecules of medicinal interest within drug discovery programs, using state of the art synthetic methods.
The student will be supervised by an experienced synthetic chemist. Students also can familiarize themselves with high-throughput experimentation and parallel synthesis. Finally, students will participate in chemistry meetings and, when possible, also computer-aided drug design meetings.
